Skip to content
A LGX50mg

Drawing based on the label description. No photo yet.

A LGX 50mg pill

Pill with imprint A LGX 50mg is orange & pink, capsule, 22 mm and has been identified as Encorafenib 50 mg. It is used for melanoma. It is supplied by Array Biopharma Inc.

Encorafenib 50 mg

Imprint
A LGX 50mg
Strength
50 mg
Used for
Melanoma
Color
Orange, Pink
Shape
Capsule / oblong
Size
22 mm
Score
No score line
Form
Capsule
Manufacturer
Array Biopharma Inc
NDC
70255-050, 70255-050-28

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Encorafenib pills and guides

What is Encorafenib used for?

Encorafenib is used for melanoma.

Official uses from the US prescribing label

BRAF V600E or V600K Mutation–Positive Unresectable or Metastatic Melanoma

BRAFTOVI is indicated, in combination with binimetinib, for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by an FDA-authorized test.

BRAF V600E Mutation-Positive Metastatic Colorectal Cancer (mCRC)

  • BRAFTOVI is indicated, in combination with cetuximab and fluorouracil-based chemotherapy, for the treatment of adult patients with metastatic colorectal cancer (mCRC) with a BRAF V600E mutation, as detected by an FDA-authorized test.
  • BRAFTOVI is indicated, in combination with cetuximab, for the treatment of adult patients with mCRC with a BRAF V600E mutation, as detected by an FDA-authorized test, after prior therapy.

BRAF V600E Mutation-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC)

BRAFTOVI is indicated, in combination with binimetinib, for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) with a BRAF V600E mutation, as detected by an FDA-authorized test.

Limitations of Use

BRAFTOVI is not indicated for treatment of patients with wild-type BRAF melanoma, wild-type BRAF CRC, or wild-type BRAF NSCLC.

From the FDA-approved label on DailyMed (published Mar 02, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows A LGX 50mg. The parts can be split between the two sides, so turn the pill over and check both.
  • It is orange & pink, capsule, 22 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Braftovi.

Ingredients

Active: Encorafenib

Inactive: Copovidone K25-31, Poloxamer 188, Microcrystalline Cellulose, Succinic Acid, Crospovidone, Unspecified, Silicon Dioxide, Magnesium Stearate, Gelatin, Unspecified, Titanium Dioxide, Ferric Oxide Red, Ferric Oxide Yellow, Ferrosoferric Oxide, Shellac, Propylene Glycol

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Encorafenib pills